The Bone Growth Stimulator Market is segmented by Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), and Platelet-rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union and Non-Union Bone Fractures, Oral and Maxillofacial Surgeries, and Other Applications), End User (Hospitals and Clinics, Home Care, and Other Applications) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The bone growth stimulator market was valued at approximately USD 985 million in 2020 and is expected to a CAGR of 6.9% over the forecast period.
A bone growth stimulator is a device that stimulates the natural healing of bones by sending low‑level pulses of electromagnetic energy to the injury or fusion site. A bone growth stimulator is beneficial after a multi-level fusion procedure or for patients who have certain comorbidities, such as smoking addiction or diabetes.
The rising incidence of bone and joint disorders, growing demand for non-invasive and minimally invasive surgeries across the world, and the growing geriatrics population are some of the factors that have supported long-term expansion for Bone Growth Stimulator Market.
The impact of COVID-19 on the studied market is expected to be significant. On one hand, due to the lockdown and travel restriction imposed to combat the transmission of the COVID-19 virus, incidences of road accidents and consequent fractures and injuries have reduced, which has highly impacted the studied market.
North America holds the largest share of the bone growth stimulator market. This is majorly attributed to the increasing geriatric population and the growing burden of orthopaedic diseases in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 6.9% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
product, application, end user and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Medtronic plc, Johnson and Johnson (Depuy Synthes), Bioventus LLC, Orthofix International N.V., Zimmer Biomet, and Stryker Corporation. |
Available Customization |
In addition to the market data for Bone Growth Stimulator Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Bone Growth Stimulator Market is segmented into product, application, end user and region.